{"DataElement":{"publicId":"7653578","version":"1","preferredName":"Baseline Characteristic Sarcoma by FNCLCC Grade","preferredDefinition":"The assignment of a position on a scale of quality to describe the microscopic physical features of cells according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC).","longName":"7653571v1.0:7653573v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7653571","version":"1","preferredName":"Baseline Characteristics Sarcoma by FNCLCC Grade","preferredDefinition":"Subject data gathered prior to an event or intervention, which may include medical history, demographic, and clinical data._Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.","longName":"7652419v1.0:7653579v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7652419","version":"1","preferredName":"Baseline Characteristics","preferredDefinition":"Subject data gathered prior to an event or intervention, which may include medical history, demographic, and clinical data.","longName":"C142401","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline Characteristics","conceptCode":"C142401","definition":"Subject data gathered prior to an event or intervention, which may include medical history, demographic, and clinical data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AB4F43-5241-0A4F-E053-4EBD850A7ADA","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7653579","version":"1","preferredName":"Sarcoma by FNCLCC Grade","preferredDefinition":"Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.","longName":"C9023","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma by FNCLCC Grade","conceptCode":"C9023","definition":"Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C223C2B5-4262-6BAD-E053-4EBD850A88D9","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C22389CC-C166-0989-E053-4EBD850A4E52","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"SOKKERL","dateModified":"2023-09-30","changeDescription":null,"administrativeNotes":"9/30/23 Released SAR AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7653573","version":"1","preferredName":"Sarcoma by FNCLCC Grade","preferredDefinition":"Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma._A position on a scale of intensity or amount or quality.","longName":"7653573v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"G3 Grade 3","valueDescription":"FNCLCC Sarcoma Grade 3","ValueMeaning":{"publicId":"6102879","version":"1","preferredName":"FNCLCC Sarcoma Grade 3","longName":"6102879","preferredDefinition":"A sarcoma with a total score of 6 or higher according to the FNCLCC guidelines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma G3","conceptCode":"C9029","definition":"A sarcoma with a total score of 6 or higher according to the FNCLCC guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B7CD99-D0CF-0E20-E053-F662850A9CB0","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C223A6E9-64BA-1AAB-E053-4EBD850A3FD4","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"},{"value":"G2 Grade 2","valueDescription":"FNCLCC Sarcoma Grade 2","ValueMeaning":{"publicId":"6102881","version":"1","preferredName":"FNCLCC Sarcoma Grade 2","longName":"6102881","preferredDefinition":"A sarcoma with a total score of 4 or 5 according to the FNCLCC guidelines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma G2","conceptCode":"C9028","definition":"A sarcoma with a total score of 4 or 5 according to the FNCLCC guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B7CD99-D0F5-0E20-E053-F662850A9CB0","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C223A6E9-64CF-1AAB-E053-4EBD850A3FD4","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"},{"value":"G1 Grade 1","valueDescription":"FNCLCC Sarcoma Grade 1","ValueMeaning":{"publicId":"7653575","version":"1","preferredName":"FNCLCC Sarcoma Grade 1","longName":"7653575","preferredDefinition":"A sarcoma with a total score of 2 or 3 according to the FNCLCC guidelines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma G1","conceptCode":"C9024","definition":"A sarcoma with a total score of 2 or 3 according to the FNCLCC guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C223A6E9-64DD-1AAB-E053-4EBD850A3FD4","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C223A6E9-64F6-1AAB-E053-4EBD850A3FD4","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"},{"value":"GX Grade cannot be assessed","valueDescription":"FNCLCC Sarcoma Grade GX Grade cannot be assessed","ValueMeaning":{"publicId":"7653577","version":"1","preferredName":"FNCLCC Sarcoma Grade GX Grade cannot be assessed","longName":"7653577","preferredDefinition":"A sarcoma with a GX  grade that cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FNCLCC Sarcoma Grade GX Grade cannot be assessed","conceptCode":"C160730","definition":"A sarcoma with a GX  grade that cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C223A6E9-6503-1AAB-E053-4EBD850A3FD4","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C223A6E9-651C-1AAB-E053-4EBD850A3FD4","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7653572","version":"1","preferredName":"Sarcoma by FNCLCC Grade Grade","preferredDefinition":"Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.:A position on a scale of intensity or amount or quality.","longName":"C9023:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma by FNCLCC Grade","conceptCode":"C9023","definition":"Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C223A6E9-6488-1AAB-E053-4EBD850A3FD4","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C223A6E9-6499-1AAB-E053-4EBD850A3FD4","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"SOKKERL","dateModified":"2023-09-30","changeDescription":null,"administrativeNotes":"9/30/23 Released SAR AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218984","version":"1","longName":"Soft Tissue","context":"OCCPR"},{"publicId":"7634335","version":"1","longName":"SAR Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Grade (FNCLCC Grad","type":"Preferred Question Text","description":"Histologic Grade (FNCLCC Grading system) (excludes GISTs)","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Incomplete","id":"C223AEF2-35B2-1188-E053-4EBD850A1F35","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"SOKKERL","dateModified":"2023-09-30","changeDescription":"5/19/21 jk syn approved by EVS; def upd.  5/12/ls waiting on synonym approval from EVS for C9023.","administrativeNotes":"8/22/22 “Incomplete” RS is pending curation of the CPTAC SAR baseline CRF. per jk.  MR; 9/30/23 Released SAR AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}